Literature DB >> 15389927

Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome.

Kimberly F Kerstann1, Eleanor Feingold, Sallie B Freeman, Lora J H Bean, Robert Pyatt, Stuart Tinker, Amy H Jewel, George Capone, Stephanie L Sherman.   

Abstract

Many of the birth defects associated with trisomy exhibit both variable expressivity and incomplete penetrance. This variability suggests that it is allelic variation and not simply the presence of an additional chromosome that leads to the development of certain trisomy-associated birth defects. With the proper tools, one may use trisomic populations to identify genes involved in the development of specific birth defects. A trisomic population may be advantageous over a normal population if the defect is over-represented in the trisomic population. Alternatively, one can view the trisomic populations as a "model system" to offer insight into aspects of both normal and abnormal embryonic development. Standard disomic linkage disequilibrium mapping approaches need to be adjusted to account for the presence of the additional genetic material in the trisomic individuals. We present an approach for linkage disequilibrium mapping of variable phenotypes in a trisomic population that adequately accounts for the additional alleles and the pattern of non-independent inheritance. We establish the laboratory methods and statistical tools necessary to conduct an association study in a trisomic population. As an example, we have applied these tools to a pilot study of Down syndrome-associated congenital heart defects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389927     DOI: 10.1002/gepi.20019

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  11 in total

1.  Neurodevelopmental outcomes in children with Down syndrome and congenital heart defects.

Authors:  Jeannie Visootsak; William T Mahle; Paul M Kirshbom; Lillie Huddleston; Marcia Caron-Besch; Amy Ransom; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2011-09-19       Impact factor: 2.802

2.  Smarter clustering methods for SNP genotype calling.

Authors:  Yan Lin; George C Tseng; Soo Yeon Cheong; Lora J H Bean; Stephanie L Sherman; Eleanor Feingold
Journal:  Bioinformatics       Date:  2008-09-29       Impact factor: 6.937

3.  Influence of CHDs on psycho-social and neurodevelopmental outcomes in children with Down syndrome.

Authors:  Jeannie Visootsak; Lillie Huddleston; Allison Buterbaugh; Adrienne Perkins; Stephanie Sherman; Jessica Hunter
Journal:  Cardiol Young       Date:  2015-02-16       Impact factor: 1.093

4.  Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.

Authors:  Samantha L Deitz; Randall J Roper
Journal:  Genetics       Date:  2011-09-16       Impact factor: 4.562

5.  ALK2 mutation in a patient with Down's syndrome and a congenital heart defect.

Authors:  Irene C Joziasse; Kelly A Smith; Sonja Chocron; Maarten van Dinther; Victor Guryev; Jasper J van de Smagt; Edwin Cuppen; Peter Ten Dijke; Barbara Jm Mulder; Cheryl L Maslen; Benjamin Reshey; Pieter A Doevendans; Jeroen Bakkers
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

6.  Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome.

Authors:  Adam E Locke; Kenneth J Dooley; Stuart W Tinker; Soo Yeon Cheong; Eleanor Feingold; Emily G Allen; Sallie B Freeman; Claudine P Torfs; Clifford L Cua; Michael P Epstein; Michael C Wu; Xihong Lin; George Capone; Stephanie L Sherman; Lora J H Bean
Journal:  Genet Epidemiol       Date:  2010-09       Impact factor: 2.135

7.  Understanding the basis for Down syndrome phenotypes.

Authors:  Randall J Roper; Roger H Reeves
Journal:  PLoS Genet       Date:  2006-03       Impact factor: 5.917

8.  A novel procedure for genotyping of single nucleotide polymorphisms in trisomy with genomic DNA and the invader assay.

Authors:  Kelly J Duffy; Jack Littrell; Adam Locke; Stephanie L Sherman; Michael Olivier
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

9.  Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease.

Authors:  Anne-Sophie Jannot; Anna Pelet; Alexandra Henrion-Caude; Asma Chaoui; Marine Masse-Morel; Stacey Arnold; Damien Sanlaville; Isabella Ceccherini; Salud Borrego; Robert M W Hofstra; Arnold Munnich; Nadège Bondurand; Aravinda Chakravarti; Françoise Clerget-Darpoux; Jeanne Amiel; Stanislas Lyonnet
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

10.  The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome.

Authors:  M Reza Sailani; Periklis Makrythanasis; Armand Valsesia; Federico A Santoni; Samuel Deutsch; Konstantin Popadin; Christelle Borel; Eugenia Migliavacca; Andrew J Sharp; Genevieve Duriaux Sail; Emilie Falconnet; Kelly Rabionet; Clara Serra-Juhé; Stefano Vicari; Daniela Laux; Yann Grattau; Guy Dembour; Andre Megarbane; Renaud Touraine; Samantha Stora; Sofia Kitsiou; Helena Fryssira; Chariklia Chatzisevastou-Loukidou; Emmanouel Kanavakis; Giuseppe Merla; Damien Bonnet; Luis A Pérez-Jurado; Xavier Estivill; Jean M Delabar; Stylianos E Antonarakis
Journal:  Genome Res       Date:  2013-06-19       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.